Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma
W. M. Kamp, C. M. Sellers, S. M. Stein, J. K. Lim, H. S. Kim
This study shows that direct-acting antivirals (DAAs) and achieving SVR12 improve survival in HCV-positive patients with hepatocellular carcinoma.
bioRxiv · Mar 12, 2019Immunology